Aldehyde Dehydrogenase (ALDH)
Aldehyde dehydrogenase 1 (ALDH1), which is a putative marker of breast cancer stem cells (CSCs), in triple negative breast cancer (TNBC) tissues.
Mitochondrial aldehyde dehydrogenase (ALDH2) is a member of the 19-strong human aldehyde dehydrogenase family of NADP+-dependent enzymes.
ALDH2, a mitochondrial enzyme responsible for metabolizing the major lipid peroxidation product, protects against acute ischemia/reperfusion injury and chronic heart failure. Activation of ALDH2, the main enzyme that catalyzes 4-HNE metabolism, is sufficient to protect the heart against acute ischemia-reperfusion injury.
ALDH2 is a key detoxifying enzyme. ALDH2 is most commonly associated with its role in ethanol metabolism, catalyzing the oxidation of ethanol-derived acetaldehyde to acetate.
Targets for Aldehyde Dehydrogenase (ALDH)
Products for Aldehyde Dehydrogenase (ALDH)
- Cat.No. Product Name Information
- GC39328 3-Hydroxybenzaldehyde 3-Hydroxybenzaldehyde?is a precursor compound for phenolic compounds, such as Protocatechualdehyde.
- GC39245 4-Diethylaminobenzaldehyde 4-Diethylaminobenzaldehyde is a reversible aldehyde dehydrogenases (ALDHs) inhibitor, with a Ki of 4 nM for ALDH1. 4-Diethylaminobenzaldehyde displays potent anti-androgenic effect (IC50= 1.71μM).
-
GC42410
4-hydroxy Nonenal
A lipid peroxidation product
- GC50613 673 A ALDH1A inhibitor; depletes CD133+ cancer stem cells (CSC)
-
GC16597
Alda 1
ALDH2 activator
- GC64063 ALDH1A1-IN-2 ALDH1A1-IN-2 is a potent inhibitor of aldehyde dehydrogenase 1a1 (aldh1a1). Aldehyde dehydrogenases (ALDH) constitute a family of enzymes that play a critical role in oxidizing various cytotoxic xenogenic and biogenic aldehydes. ALDH1A1-IN-2 has the potential for the research of cancer, inflammation, or obesity (extracted from patent WO2019089626A1, compound 295).
- GC67782 ALDH1A2-IN-1
- GC68464 ALDH1A3-IN-1
- GC68462 ALDH1A3-IN-2
- GC64618 ALDH1A3-IN-3 ALDH1A3-IN-3 (compound 16) is a potent inhibitor of ALDH1A3, with an IC50 of 0.26 μM. ALDH1A3-IN-3 is also a good ALDH3A1 substrate. ALDH1A3-IN-3 can be used for the research of prostate cancer.
- GC60092 BODIPY aminoacetaldehyde BODIPY aminoacetaldehyde (BAAA) is a fluorescent substrate for both murine and human aldehyde dehydrogenase (ALDH). BODIPY aminoacetaldehyde consists of an aminoacetaldehyde moiety bonded to the BODIPY fluorochrome and can be used to label stem cells.
- GC43285 CM037 CM037 is a selective inhibitor of aldehyde dehydrogenase 1A1 (ALDH1A1; IC50 = 4.6 μM).
- GC39215 CM10 CM10 is a potent and selective aldehyde dehydrogenase 1A (ALDH1A) family inhibitor, with IC50s of 1700, 740, and 640 nM for ALDH1A1, ALDH1A2, and ALDH1A3, respectively.
- GC10902 CVT 10216 reversible inhibitor of aldehyde dehydrogenase 2 (ALDH2)
- GC10801 Disulfiram An irreversible inhibitor of aldehyde dehydrogenase
-
GC38909
EN40
EN40 is a potent, selective aldehyde dehydrogenase 3A1 (ALDH3A1) inhibitor as a covalent ligand, exhibits an IC50 value of 2 uM
- GC68009 KS106
-
GC10016
NCT-501
Aldehyde Dehydrogenase 1A1 (ALDH1A1) inhibitor, Potent and Selective
- GC44338 NCT-501 (hydrochloride) Aldehyde dehydrogenases (ALDHs) catalyze the NAD(P)+-dependent oxidation of aldehyde-containing substrates to the corresponding carboxylic acids.
- GC33219 NCT-505 NCT-505 is a potent and selective aldehyde dehydrogenase (ALDH1A1) inhibitor, with an IC50 of 7 nM, and weakly inhibits hALDH1A2, hALDH1A3, hALDH2, hALDH3A1 (IC50s, >57, 22.8, 20.1, >57 μM).
- GC65274 NCT-506 NCT-506 is an orally bioavailable aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with an IC50 of 7 nM.
- GC46002 Prunetin An isoflavone with diverse biological activities
- GC37576 RV01 RV01 is an analogue of resveratrol, inhibits DNA damage, reduces acetaldehyde dehydrogenase 2 (ALDH2) mRNA expression induced by ethanol, and exhibits hydroxyl radical scavenging activity.
- GC63605 Taraxerone Taraxerone is isolated from Sedum sarmentosum.